Innoviva
INVA
146 hedge funds and large institutions have $2.76B invested in Innoviva in 2014 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 60 increasing their positions, 48 reducing their positions, and 24 closing their positions.
25% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 48
9% more call options, than puts
Call options by funds: $12.5M | Put options by funds: $11.5M
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
8% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 24
2% less funds holding
Funds holding: 149 → 146 (-3)
33% less capital invested
Capital invested by funds: $4.11B → $2.76B (-$1.36B)
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$203M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$81M |
| 3 |
BG
Baupost Group
Boston,
Massachusetts
|
+$20.4M |
| 4 |
PCM
Proxima Capital Management
New York
|
+$18.7M |
| 5 |
First Manhattan
New York
|
+$14.3M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$26.9M |
| 2 |
HM
HealthCor Management
New York
|
-$25.8M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$23.7M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$22.6M |
| 5 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$18.2M |
INVA Hedge Fund Activity: Q1 2014 in Review
146 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q1 2014, worth a combined $2.76B — down 33% from $4.11B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of INVA and 22 opened new positions — a net loss of 2 holders — while 48 trimmed existing stakes and 60 added.
The largest buyer was Capital World Investors, adding an estimated $203M. The largest seller was Fidelity Investments, cutting an estimated $26.9M.
- 146 institutional investors held Innoviva (INVA) as of Q1 2014, down from 149 in Q4 2013.
- Funds reported $2.76B of Innoviva stock for Q1 2014, down 33% quarter-over-quarter.
- 22 funds opened new Innoviva positions in Q1 2014 and 24 closed out, a net change of -2 holders.
- The largest Innoviva buyer in Q1 2014 was Capital World Investors, an estimated $203M added.
- The largest Innoviva seller in Q1 2014 was Fidelity Investments, an estimated $26.9M sold.
Based on aggregated 13F filings for Q1 2014.